Boehringer Ingelheim
Home
Locations
 

Boehringer Ingelheim Corporation


Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc. is the largest subsidiary of Boehringer Ingelheim Corporation, located in Ridgefield, Connecticut. It is the worldwide Center of Excellence in immunology, inflammatory disease, and cardiovascular research.


Boehringer Ingelheim Roxane, Inc.

Roxane Laboratories, Inc.

Boehringer Ingelheim Roxane, Inc. and Roxane Laboratories, Inc. are located in Columbus, Ohio and are subsidiaries of Boehringer Ingelheim Corporation. These subsidiaries are recognized leaders in researching, manufacturing and packaging brand name and generic medications including oral liquids, tablets and capsules.


Ben Venue Laboratories, Inc.

The leading producer of sterile injectables for the U.S. pharmaceutical industry, Ben Venue Laboratories, Inc. is based in Bedford, Ohio. It also markets its own line of generic injectables to hospitals in North America through its Bedford Laboratories division.


Boehringer Ingelheim Vetmedica, Inc.

Located in St. Joseph, Missouri, Boehringer Ingelheim Vetmedica, Inc. is a leading supplier of animal health products for livestock producers and veterinarians. Vetmedica is a Center of Competence in biologicals research for Boehringer Ingelheim's worldwide animal health business.


Boehringer Ingelheim Chemicals

A wholly owned subsidiary of the Boehringer Ingelheim Corporation since 1991, Boehringer Ingelheim Chemicals is located in Petersburg, Virginia. The company produces drug substances and intermediates for the pharmaceutical industry. Production is carried out in FDA inspected cGMP facilities. The site has ISO 9002 certification and is DEA licensed for C-II controlled substances.


Boehringer Ingelheim GmbH

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 144 affiliates in 45 countries and nearly 36,000 employees. Since it was founded in 1885, the privately-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.